Nutrition and skin: Kids are not just little people

Clinics in Dermatology

Volumn 34, Issue 6, 2016, Pages 698-709

  McCusker, Meagen ^a   Sidbury, Robert ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; ESSENTIAL FATTY ACID; FISH OIL; FOLIC ACID PLUS NICOTINAMIDE PLUS ZINC OXIDE; HISTAMINE; HORMONE RECEPTOR; INSULIN; PREBIOTIC AGENT; PROBIOTIC AGENT; RETINOID; RETINOL DERIVATIVE; SOMATOMEDIN C; VITAMIN D; VITAMIN D DERIVATIVE; ZINC; RETINOL;

ACHLORHYDRIA; ACNE; AGE DISTRIBUTION; ALOPECIA AREATA; ARTICLE; ATOPIC DERMATITIS; BACTERIAL OVERGROWTH; BIFIDOBACTERIUM; BODY WEIGHT; CARDIOVASCULAR RISK; DIETARY SUPPLEMENT; DRUG EFFECT; DRUG USE; ECZEMA; ENTEROPATHY; FOOD ALLERGY; GLUTEN FREE DIET; HELICOBACTER INFECTION; HOMEOPATHY; HUMAN; INNATE IMMUNITY; LACTATION; LACTOBACILLUS; LIFESTYLE; MATERNAL NUTRITION; MILK; NONHUMAN; NUTRIENT MANAGEMENT; NUTRITIONAL HEALTH; OBESITY; PANCREAS INSUFFICIENCY; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PSORIASIS; RISK ASSESSMENT; ROSACEA; SENSITIZATION; SKIN DISEASE; SMOKING; STRESS; VERRUCA VULGARIS; VITAMIN BLOOD LEVEL; ACNE VULGARIS; ADOLESCENT; ADULT; ADVERSE EFFECTS; AGE; BLOOD; CARDIOVASCULAR DISEASES; CHILD; COMPARATIVE STUDY; COMPLICATION; DERMATITIS, ATOPIC; DIET; FEMALE; GASTROINTESTINAL DISEASE; INFANT; METABOLISM; NEWBORN; PRENATAL EXPOSURE; PRESCHOOL CHILD; RECURRENT DISEASE;

ACNE VULGARIS; ADOLESCENT; ADULT; AGE FACTORS; ALOPECIA AREATA; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DIET; DIETARY SUPPLEMENTS; FEMALE; FISH OILS; GASTROINTESTINAL DISEASES; HUMANS; INFANT; INFANT, NEWBORN; LACTATION; OBESITY; PREBIOTICS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROBIOTICS; PSORIASIS; ROSACEA; SYMPTOM FLARE UP; VITAMIN A; VITAMIN D;

EID: 84992731503     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2016.07.004     Document Type: Article

References (123)

1. [1] Watson, W, Kapur, S, Atopic dermatitis. Allergy Asthma Clin Immunol 7:suppl 1 (2011), S1492–S1497.
2. [2] Peng, W, Novak, N, Recent developments in atopic dermatitis. Curr Opin Allergy Clin Immunol 4 (2014), 417–422.
3. [3] Reid, G, Burton, J, Use of lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 4 (2002), 319–324.
4. [4] Ulluwishewa, D, Anderson, RC, McNabb, WC, et al. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 1 (2011), 769–776.
5. [5] Singh, V, Singh, K, Amdekar, S, et al. Innate and specific gut-associated immunity and microbial interference. FEMS Immunol Med Microbiol 55 (2009), 6–12.
6. [6] Bengmark, S, Colonic food: pre- and probiotics. Am J Gastroenterol 95 (2000), S5–S7.
7. [7] Pfefferle, PI, Prescott, SL, Kopp, M, Microbial influence on tolerance and opportunities for intervention with prebiotics/probiotics and bacterial lysates. J Allergy Clin Immunol 13 (2013), 1453–1463.
8. [8] Resta, SC, Effects of probiotics and commensals on intestinal epithelial physiology: implications for nutrient handling. J Physiol 587 (2009), 4169–4174.
9. [9] Macfarlane, GT, Macfarlane, S, Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int 95 (2012), 50–60.
10. [10] Magrone, T, Jirillo, E, The interplay between the gut immune system and microbiota in health and disease: nutraceutical intervention for restoring intestinal homeostasis. Curr Pharm Des 19 (2013), 1329–1342.
11. [11] Cross, ML, Stevenson, LM, Gill, HS, Anti-allergy properties of fermented foods: an important immunoregulatory mechanism of lactic acid bacteria?. Int Immunopharmacol 1 (2001), 891–901.
12. [12] Kim, DH, Lee, JW, Kim, IS, et al. Successful treatment of alopecia areata with topical calcipotriol. Ann Dermatol 24 (2012), 341–344.
13. [13] Zeiger, RS, Heller, S, Mellon, MH, et al. Effect of combined maternal and infant food-allergen avoidance on development of atopy in early infancy: a randomized study. J Allergy Clin Immunol 84 (1989), 72–89.
14. [14] Zeiger, RS, Heller, S, Mellon, MH, Genetic and environmental factors affecting the development of atopy through age 4 in children of atopic parents: a prospective randomized study of food allergen avoidance. Pediatr Allergy Immunol 3 (1992), 110–127.
15. [15] Zeiger, RS, Heller, S, The development and prediction of atopy in high-risk children: follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol 95 (1995), 1179–1190.
16. [16] Rautava, S, Kalliomaki, M, Isolauri, E, Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 109 (2002), 119–121.
17. [17] Denburg, JA, Hatfield, HM, Cyr, MM, et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatr Res 57 (2005), 276–281.
18. [18] Ramesh, S, Food allergy overview in children. Clin Rev Allergy Immunol 34 (2008), 217–230.
19. [19] Monti, G, Muratore, MC, Peltran, A, et al. High incidence of adverse reactions to egg challenge on first known exposure in young atopic dermatitis children: predictive value of skin prick test and radioallergosorbent test to egg proteins. Clin Exp Allergy 32 (2002), 1515–1519.
20. [20] Veien, NK, Hattel, T, Laurberg, G, Low nickel diet: an open, prospective trial. J Am Acad Dermatol 29 (1993), 1002–1007.
21. [21] Asano, Y, Makino, T, Norisugi, O, et al. Occupational cobalt induced systemic contact dermatitis. Eur J Dermatol 19 (2009), 166–167.
22. [22] Lowther, A, McCormick, T, Nedorost, S, Systemic contact dermatitis from propylene glycol. Dermatitis 19 (2008), 105–108.
23. [23] Fabbro, SK, Zirwas, MJ, Systemic contact dermatitis to foods: nickel, BOP, and more. Curr Allergy Asthma Rep, 14, 2014, 463.
24. [24] Carey, AB, Cornish, K, Schrank, P, et al. Cross-reactivity of alternate plant sources of latex in subjects with systemic IgE-mediated sensitivity to Hevea brasiliensis latex. Ann Allergy Asthma Immunol 74 (1995), 317–320.
25. [25] Veien, NK, Lomholt, HB, Systemic allergic dermatitis presumably caused by formaldehyde derived from aspartame. Contact Dermatitis 67 (2012), 315–316.
26. [26] Scheman, A, Rakowski, EM, Chou, V, et al. Balsam of Peru: past and future. Dermatitis 24 (2013), 153–160.
27. [27] Newland, K, Warren, L, Gold, M, Food allergy testing in infantile eczema: a clinical approach and algorithm. Australas J Dermatol 54 (2013), 79–84.
28. [28] Bath-Hextall, F, Delamere, FM, Williams, HC, Dietary exclusions for established atopic eczema. Cochrane Database Syst Rev, 1, 2008, CD005203.
29. [29] Bath-Hextall, F, Delamere, FM, Williams, HC, Dietary exclusions for improving established atopic eczema in adults and children: systematic review. Allergy 64 (2009), 258–264.
30. [30] Neild, VS, Marsden, RA, Bailes, JA, et al. Egg and milk exclusion diets in atopic eczema. Br J Dermatol 114 (1986), 117–123.
31. [31] Adachi, A, Horikawa, T, Takashima, T, et al. Potential efficacy of low metal diets and dental metal elimination in the management of atopic dermatitis: an open clinical study. J Dermatol 24 (1997), 12–19.
32. [32] Wobke, TK, Sorg, BL, Steinhilber, D, Vitamin D in inflammatory diseases. Front Physiol, 5, 2014, 244.
33. [33] Ghaly, S, Lawrance, I, The role of vitamin D in gastrointestinal inflammation. Expert Rev Gastroenterol Hepatol, 1-15, 2014.
34. [34] Wang, B, Jing, Z, Li, C, et al. Blood 25-hydroxyvitamin D levels and overall mortality in patients with colorectal cancer: a dose-response meta-analysis. Eur J Cancer 50 (2014), 2173–2175.
35. [35] Zittermann, A, Prokop, S, The role of vitamin D for cardiovascular disease and overall mortality. Adv Exp Med Biol 810 (2014), 106–119.
36. [36] Akan, A, Azkur, D, Ginis, T, et al. Vitamin D level in children is correlated with severity of atopic dermatitis but only in patients with allergic sensitizations. Pediatr Dermatol 30 (2013), 359–363.
37. [37] Baek, JH, Shin, YH, Chung, IH, et al. The link between serum vitamin D level, sensitization to food allergens, and the severity of atopic dermatitis in infancy. J Pediatr 165 (2014), 849–854.
38. [38] Camargo, CA, Ganmaa, D, Sidbury, R, et al. Randomized trial of vitamin D supplementation for winter-related atopic dermatitis. J Allergy Clin Immunol 134 (2014), 831–835.
39. [39] Ricketts, JR, Rothe, MJ, Grant-Kels, JM, Nutrition and psoriasis. Clin Dermatol 28 (2010), 615–626.
40. [40] Paller, AS, Mercy, K, Kwasny, MJ, et al. Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. JAMA Dermatol 149 (2013), 166–176.
41. [41] Wakkee, M, Herings, RM, Nijsten, T, Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol 130 (2010), 962–967.
42. [42] Kimball, AB, Wu, EQ, Guerin, A, et al. Risks of developing psychiatric disorders in pediatric patients with psoriasis. J Am Acad Dermatol 67 (2012), 651–657.
43. [43] Bhole, VM, Choi, HK, Burns, LC, et al. Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology (Oxford) 51 (2012), 552–556.
44. [44] Naldi, L, Conti, A, Cazzaniga, S, et al. Diet and physical exercise in psoriasis: a randomized controlled trial. Br J Dermatol 170 (2014), 634–642.
45. [45] Langan, SM, Seminara, NM, Shin, DB, et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 132 (2012), 556–562.
46. [46] Armstrong, AW, Harskamp, CT, Armstrong, EJ, Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol 68 (2013), 654–662.
47. [47] Fotiadou, C, Lazaridou, E, Ioannides, D, Management of psoriasis in adolescence. Adolesc Health Med Ther 5 (2014), 25–34.
48. [48] Torres, T, Machado, S, Mendonca, D, et al. Cardiovascular comorbidities in childhood psoriasis. Eur J Dermatol 24 (2014), 229–235.
49. [49] Goldminz, AM, Buzney, CD, Kim, N, et al. Prevalence of the metabolic syndrome in children with psoriatic disease. Pediatr Dermatol 30 (2013), 700–705.
50. [50] Roongpisuthipong, W, Pongpudpunth, M, Roongpisuthipong, C, et al. The effect of weight loss in obese patients with chronic stable plaque-type psoriasis. Dermatol Res Pract, 2013, 2013, 795932.
51. [51] Gisondi, P, Del Giglio, M, Di Francesco, V, et al. Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. Am J Clin Nutr 88 (2008), 1242–1247.
52. [52] Jensen, P, Zachariae, C, Christensen, R, et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatol 149 (2013), 795–801.
53. [53] Hossler, EW, Maroon, MS, Mowad, CM, Gastric bypass surgery improves psoriasis. J Am Acad Dermatol 65 (2011), 198–200.
54. [54] Hossler, EW, Wood, GC, Still, CD, et al. The effect of weight loss surgery on the severity of psoriasis. Br J Dermatol 168 (2013), 660–661.
55. [55] Higa-Sansone, G, Szomstein, S, Soto, F, et al. Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 14 (2004), 1132–1134.
56. [56] de Menezes Ettinger, JE, Azaro, E, de Souza, CA, et al. Remission of psoriasis after open gastric bypass. Obes Surg 16 (2006), 94–97.
57. [57] Mayser, P, Mrowietz, U, Arenberger, P, et al. Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol 38 (1998), 539–547.
58. [58] Balbas, GM, Regana, MS, Millet, PU, Study on the use of omega-3 fatty acids as a therapeutic supplement in treatment of psoriasis. Clin Cosmet Investig Dermatol 4 (2011), 73–77.
59. [59] Escobar, SO, Achenbach, R, Iannantuono, R, et al. Topical fish oil in psoriasis—a controlled and blind study. Clin Exp Dermatol 17 (1992), 159–162.
60. [60] Marsden, JR, Effect of dietary fish oil on hyperlipidaemia due to isotretinoin and etretinate. Hum Toxicol 6 (1987), 219–222.
61. [61] Ricceri, F, Pescitelli, L, Tripo, L, et al. Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis. J Am Acad Dermatol 68 (2013), 511–512.
62. [62] Perez, A, Raab, R, Chen, TC, et al. Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis. Br J Dermatol 34 (1996), 1070–1078.
63. [63] Finamor, DC, Sinigaglia-Coimbra, R, Neves, LC, et al. A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis. Dermatoendocrinol 5 (2012), 222–234.
64. [64] Kharaeva, Z, Gostova, E, De Luca, C, et al. Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients. Nutrition 25 (2009), 295–302.
65. [65] Ludvigsson, JF, Lindelof, B, Zingone, F, et al. Psoriasis in a nationwide cohort study of patients with celiac disease. J Invest Dermatol 131 (2011), 2010–2016.
66. [66] Michaelsson, G, Gerden, B, Hagforsen, E, et al. Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet. Br J Dermatol 142 (2000), 44–51.
67. [67] Fulton, JE Jr., Plewig, G, Kligman, AM, Effect of chocolate on acne vulgaris. JAMA 210 (1969), 2071–2074.
68. [68] Anderson, PC, Foods as the cause of acne. Am Fam Physician 3 (1971), 102–103.
69. [69] Cordain, L, Lindeberg, S, Hurtado, M, et al. Acne vulgaris: a disease of western civilization. Arch Dermatol 138 (2002), 1584–1590.
70. [70] Deplewski, D, Rosenfeld, RL, Role of hormones in pilosebaceous unit development. Endocr Rev 21 (2000), 363–392.
71. [71] Horton, R, Pasupuletti, V, Antonipillai, I, Androgen induction of steroid 5 alpha-reductase may be mediated via insulin-like growth factor-I. Endocrinology 133 (1993), 447–451.
72. [72] Guercio, G, Rivarola, MA, Chaler, E, et al. Relationship between the growth hormone/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls. J Clin Endocrinol Metab 88 (2003), 1389–1393.
73. [73] Thierry van Dessel, HJ, Lee, PD, Faessen, G, et al. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome. J Clin Endocrinol Metab 84 (1999), 3030–3035.
74. [74] Norman, RJ, Dewailly, D, Legro, RS, et al. Polycystic ovary syndrome. Lancet 370 (2007), 685–697.
75. [75] Smith, RN, Mann, NJ, Braue, A, et al. The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol 57 (2007), 247–256.
76. [76] Tan, S, Hahn, S, Benson, S, et al. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance. Eur J Endocrinol 157 (2007), 669–676.
77. [77] Rubin, MG, Kim, K, Logan, AC, Acne vulgaris, mental health and omega-3 fatty acids: a report of cases. Lipids Health Dis, 7, 2008, 36.
78. [78] Ostman, EM, Liljeberg Elmstahl, HG, Bjorck, IM, Inconsistency between glycemic and insulinemic responses to regular and fermented milk products. Am J Clin Nutr 74 (2001), 96–100.
79. [79] Liljeberg Elmstahl, H, Bjorck, I, Milk as a supplement to mixed meals may elevate postprandial insulinaemia. Eur J Clin Nutr 55 (2001), 994–999.
80. [80] Hoppe, C, Molgaard, C, Juul, A, et al. High intakes of skimmed milk, but not meat, increase serum IGF-I and IGFBP-3 in eight-year-old boys. Eur J Clin Nutr 58 (2004), 1211–1216.
81. [81] Hoppe, C, Molgaard, C, Michaelsen, KF, Cow's milk and linear growth in industrialized and developing countries. Annu Rev Nutr 26 (2006), 131–173.
82. [82] Adebamowo, CA, Spiegelman, D, Berkey, CS, et al. Milk consumption and acne in adolescent girls. Dermatol Online J, 12, 2006, 1.
83. [83] Adebamowo, CA, Spiegelman, D, Berkey, CS, et al. Milk consumption and acne in teenaged boys. J Am Acad Dermatol 58 (2008), 787–793.
84. [84] Jasson, F, Nagy, I, Knol, AC, et al. Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity. Exp Dermatol 22 (2013), 587–592.
85. [85] Dreno, B, Moyse, D, Alirezai, M, et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology 203 (2001), 135–140.
86. [86] Niren, NM, Torok, HM, The nicomide improvement in clinical outcomes study (NICOS): results of an 8-week trial. Cutis 77 (2006), S17–S28.
87. [87] Zouboulis, CC, Nestoris, S, Adler, YD, et al. A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. Arch Dermatol 139 (2003), 668–670.
88. [88] Zhang, L, Anthonavage, M, Huang, Q, et al. Proopiomelanocortin peptides and sebogenesis. Ann N Y Acad Sci 994 (2003), 154–161.
89. [89] Bowe, WP, Probiotics in acne and rosacea. Cutis 92 (2013), 6–7.
90. [90] Baquerizo Nole, KL, Yim, E, Keri, JE, Probiotics and prebiotics in dermatology. J Am Acad Dermatol 71 (2014), 814–821.
91. [91] Yang, YS, Lim, HK, Hong, KK, et al. Cigarette smoke-induced interleukin-1 alpha may be involved in the pathogenesis of adult acne. Ann Dermatol 26 (2014), 11–16.
92. [92] Cribier, B, Pathophysiology of rosacea: redness, telangiectasia, and rosacea. Ann Dermatol Venereol 138 (2011), S184–S191.
93. [93] Wong, F, Rayner-Hartley, E, Byrne, MF, Extraintestinal manifestations of Helicobacter pylori: a concise review. World J Gastroenterol 20 (2014), 11950–11961.
94. [94] Parodi, A, Paolino, S, Greco, A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol 6 (2008), 759–764.
95. [95] Margolin, L, Severe rosacea associated with colon cancer recurrence. Int J Dermatol 43 (2004), 213–214.
96. [96] Rybojad, MR, Cambiaghi, S, Vignon-Pennamen, MD, et al. Nutritional deficiency and the skin in Shwachman syndrome. Br J Dermatol 135 (1996), 340–342.
97. [97] Bernstein, ML, McCusker, MM, Grant-Kels, JM, Cutaneous manifestations of cystic fibrosis. Pediatr Dermatol 25 (2008), 150–157.
98. [98] Barba, A, Rosa, B, Angelini, G, et al. Pancreatic exocrine function in rosacea. Dermatologica 165 (1982), 601–606.
99. [99] Holmes, AD, Potential role of microorganisms in the pathogenesis of rosacea. J Am Acad Dermatol 69 (2013), 1025–1032.
100. [100] Sultan, MI, Pediatric helicobacter pylori infection. Available at: http://emedicine.medscape.com/article/929452-overview [Updated 2014, Accessed September 30, 2014].
101. [101] Layton, A, Thiboutot, D, Emerging therapies in rosacea. J Am Acad Dermatol 69 (2013), S57–S65.
102. [102] Zheng, PX, Fang, HY, Yang, HB, et al. Lactobacillus pentosus strain LPS16 produces lactic acid, inhibiting multidrug-resistant Helicobacter pylori. J Microbiol Immunol Infect, 14, 2014 S1684-1182.
103. [103] Maintz, L, Novak, N, Histamine and histamine intolerance. Am J Clin Nutr 85 (2007), 1185–1196.
104. [104] Spoendlin, J, Voegel, JJ, Jick, SS, et al. Migraine, triptans, and the risk of developing rosacea: a population-based study within the United Kingdom. J Am Acad Dermatol 69 (2013), 399–406.
105. [105] Tan, J, Berg, M, Rosacea: Current state of epidemiology. J Am Acad Dermatol 69 (2013), S27–S35.
106. [106] Gabrielli, M, D'Angelo, G, Di Rienzo, T, et al. Diagnosis of small intestinal bacterial overgrowth in the clinical practice. Eur Rev Med Pharmacol Sci 17 (2013), S30–S35.
107. [107] Two, AM, Del Rosso, JQ, Kallikrein 5-mediated inflammation in rosacea: clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefit. J Clin Aesthet Dermatol 7 (2014), 20–25.
108. [108] Reich, A, Szepietowski, JC, Vasoactive peptides in the pathogenesis of psoriasis. G Ital Dermatol Venereol 143 (2008), 289–298.
109. [109] Oztas, MO, Balk, M, Ogus, E, et al. The role of free oxygen radicals in the aetiopathogenesis of rosacea. Clin Exp Dermatol 28 (2003), 188–192.
110. [110] Cohen, AF, Tiemstra, JD, Diagnosis and treatment of rosacea. J Am Board Fam Pract 15 (2002), 214–217.
111. [111] Berardesca, E, Cameli, N, Cavallotti, C, et al. Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluation. J Cosmet Dermatol 7 (2008), 8–14.
112. [112] Petukhova, L, Duvic, M, Hordinsky, M, et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 466 (2010), 113–117.
113. [113] Shih, MY, Kane, MA, Zhou, P, et al. Retinol esterification by DGAT1 is essential for retinoid homeostasis in murine skin. J Biol Chem 28 (2009), 4292–4299.
114. [114] Duriancik, DM, Lackey, DE, Hoag, KA, Vitamin A as a regulator of antigen presenting cells. J Nutr 140 (2010), 1395–1399.
115. [115] Duncan, FJ, Silva, KA, Johnson, CJ, et al. Endogenous retinoids in the pathogenesis of alopecia areata. J Invest Dermatol 133 (2013), 334–343.
116. [116] Talpur, R, Vu, J, Bassett, R, et al. Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata. J Am Acad Dermatol, 61, 2009, 592.
117. [117] Sakai, Y, Kishimoto, J, Demay, MB, Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice. J Clin Invest 107 (2001), 961–966.
118. [118] Aksu Cerman, A, Sarikaya Solak, S, Kivanc, AI, Vitamin D deficiency in alopecia areata. Br J Dermatol 170 (2014), 1299–1304.
119. [119] Lakdawala, N, Babalola, O 3rd, Fedeles, F, et al. The role of nutrition in dermatologic diseases: facts and controversies. Clin Dermatol 31 (2013), 677–700.
120. [120] Al-Gurairi, FT, Al-Waiz, M, Sharquie, KE, Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. Br J Dermatol 146 (2002), 423–431.
121. [121] Yaghoobi, R, Sadighha, A, Baktash, D, Evaluation of oral zinc sulfate effect on recalcitrant multiple viral warts: a randomized placebo-controlled clinical trial. J Am Acad Dermatol 60 (2009), 706–708.
122. [122] Lopez-Garcia, DR, Gomez-Flores, M, Arce-Mendoza, AY, et al. Oral zinc sulfate for unresponsive cutaneous viral warts: too good to be true? A double-blind, randomized, placebo-controlled trial. Clin Exp Dermatol 34 (2009), e984–e985.
123. [123] Gupta, R, Bhardwaj, OP, Manchanda, RK, Homeopathy in the treatment of warts. Br Homeopath J 80 (1991), 108–111.